What Is 19-Nortestosterone 17β-acetate

Overview

19-Nortestosterone 17β-acetate is a synthetic derivative of nandrolone, belonging to the class of 19-nor steroids. It is structurally modified from testosterone by removing the methyl group at carbon position 19 and adding an acetate ester at the 17β-hydroxyl group. This alteration increases its metabolic stability and duration of action.

Originally developed for veterinary applications, the compound enhances muscle growth and feed efficiency in livestock. Despite its structural similarity to anabolic steroids used in humans, it has never been approved for human therapeutic use due to safety and ethical concerns.

• Discovery date: First synthesized in the early 1960s during research into growth promoters for farm animals.
• Chemical structure: Features a molecular formula of C₂₀H₂₈O₃, differing from testosterone by the absence of a 19-carbon and presence of an acetate ester.
• Metabolism: Once administered, it is hydrolyzed to nandrolone, the active anabolic agent in the body.
• Administration route: Typically given via intramuscular injection in veterinary settings for sustained release.
• Half-life: The acetate ester prolongs its half-life to approximately 48–72 hours, allowing less frequent dosing.

How It Works

The biological activity of 19-Nortestosterone 17β-acetate stems from its interaction with androgen receptors after metabolic conversion. Its mechanism supports tissue-building effects, particularly in skeletal muscle.

• Androgen receptor binding: After de-esterification, the resulting nandrolone binds to androgen receptors with affinity 20% higher than testosterone, promoting protein synthesis.
• Anabolic-to-androgenic ratio: Exhibits a ratio of 10:1, meaning it favors muscle growth over virilizing effects compared to testosterone.
• Estrogenic activity: Has low aromatization potential, reducing risk of gynecomastia; converts to estrogen at less than 20% the rate of testosterone.
• Hepatotoxicity: Unlike oral 17α-alkylated steroids, it is not liver-toxic due to its parenteral esterified form.
• Doping detection: Metabolites can be detected in urine for up to 14–18 days post-administration, making it traceable in anti-doping tests.
• Insulin-like effects: Enhances amino acid uptake in muscle cells, increasing nitrogen retention by up to 30% in animal studies.

Comparison at a Glance

Below is a comparison of 19-Nortestosterone 17β-acetate with related compounds in terms of structure, potency, and use.

The table highlights that while 19-Nortestosterone 17β-acetate has moderate anabolic potency, its low androgenic activity makes it suitable for animal use without excessive masculinizing side effects. However, its detection in doping control remains a concern due to persistent metabolites.

Why It Matters

Understanding this compound is crucial for regulatory, medical, and athletic communities due to its potential for misuse and impact on food safety.

• Food safety: Residues in meat can pose health risks; the EU has set maximum residue limits (MRLs) at 0.5 μg/kg in edible tissues.
• Anti-doping: WADA has listed it as a prohibited substance since 2004, with strict testing protocols in place.
• Veterinary ethics: Its use raises animal welfare concerns due to unnatural growth acceleration and potential organ stress.
• Human misuse: Illicit use in bodybuilding persists despite lack of human safety data and legal approval.
• Environmental impact: Excreted metabolites can enter water systems, potentially disrupting aquatic endocrine systems.
• Research value: Serves as a model compound for developing selective androgen receptor modulators (SARMs) with tissue-specific effects.

As global regulations tighten on growth promoters, 19-Nortestosterone 17β-acetate remains a significant example of the intersection between agricultural efficiency, public health, and ethical science.